A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias

Published:2010-06-10 Issue:8 Volume:24 Page:1437-1444
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Pratz K W,Cho E,Levis M J,Karp J E,Gore S D,McDevitt M,Stine A,Zhao M,Baker S D,Carducci M A,Wright J J,Rudek M A,Smith B D

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2010132.pdf

Reference35 articles.

1. Larson S, Stock W . Progress in the treatment of adults with acute lymphoblastic leukemia. Curr Opin Hematol 2008; 15: 400–407.

2. Tallman MS, Gilliland DG, Rowe JM . Drug therapy for acute myeloid leukemia. Blood 2005; 106: 1154–1163.

3. Ricciardi MR, McQueen T, Chism D, Milella M, Estey E, Kaldjian E et al. Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia. Leukemia 2005; 19: 1543–1549.

4. Kornblau SM, Womble M, Qiu YH, Jackson CE, Chen W, Konopleva M et al. Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia. Blood 2006; 108: 2358–2365.

5. Hilger RA, Scheulen ME, Strumberg D . The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie 2002; 25: 511–518.

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential role of RNA sequencing in diagnosing unexplained insensitivity to conventional chemotherapy in pediatric patients with B-cell acute lymphoblastic leukemia;BMC Medical Genomics;2024-05-29

2. Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG;Blood;2023-12-07

3. Next-Generation FLT3 Inhibitors for the Treatment of FLT3-Positive AML;Pathogenesis and Treatment of Leukemia;2023

4. Efficacy analysis of different FLT3 inhibitors in patients with relapsed/refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome;eJHaem;2022-11-21

5. Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML;Frontiers in Pediatrics;2022-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3